PROPRANOLOL
Ascites
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Ascites cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NORMAL HUMAN SERUM ALBUMIN Centro Medico Issemym | Phase 4 | BBB |
Tolvaptan Konkuk University Medical Center | Phase 4 | BBB |
FUROSEMIDE University of Palermo | Phase 4 | BB |
Rifaximin Centre Hospitalier Universitaire de Besancon | Phase 4 | BB |
Spironolactone University of Padova | Phase 4 | BB |
View all 36 →
Same molecule, other indications
PROPRANOLOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →